P.1.k.018 Prevalence of nonmedical prescription drug misuse in a sample of Greek medical students

Abstract

of education, marital status, current DSM-IV Axis I diagnosis, psychiatric and medical history, family history, medications taken on a regular basis, smoking status), including data on current treatment with psychotropic drugs, were recorded. Additional rating instruments were administered, including MINI-Plus 5.0 Structured Interview, Conners’ Adult ADHD Rating Scale (CAARS), SCID II-Personality Questionnaire, quality of life measures (EUROQOL EQ-5D), drug use test Drug Use Disorders Identification Test (DUDIT), Barratt Impulsiveness Scale (BIS). Preliminary results are based on a total sample of 105 subjects (49 males, 56 females). ASRS positive were 51 subjects that represents 49% of the total sample. The most frequent primary diagnoses were anxiety disorders (N = 68), followed by mood disorders (N = 22), personality disorders (N = 11) and others (N = 4). The patients were treated with a variety of psychotropic drugs; however, none of them were receiving specific pharmacotherapy for attention deficit hyperactivity disorder, i.e., stimulants or atomoxetine. The complete results report definite aADHD diagnosis as confirmed by CAARS, psychiatric comorbidity including personality disorders and impulsivity signs, illicit substance use, and socioeconomic status, including quality of life. Our results are the first data on the prevalence and drug treatment of adult attention deficit hyperactivity disorder in the Czech Republic. The findings confirmed earlier reports indicating high rates of comorbidity of aADHD with other psychiatric conditions. Our data suggest that attention deficit hyperactivity disorder in adults is in general poorly recognized and not treated adequately.